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Abstract – As is known from various animal models, the spread of agents causing transmissi-
ble spongiform encephalopathies (TSE) after peripheral infection affects peripheral nerves before
reaching the central nervous system (CNS) and leading to a fatal end of the disease. The lack of
therapeutic approaches for TSE is partially due to the limited amount of information available on
the involvement of host biological compartments and processes in the propagation of the infectious
agent. The in vivo model presented here can provide information on the spread of the scrapie agent
via the peripheral nerves of hamsters under normal and altered axonal conditions. Syrian hamsters
were unilaterally footpad (f.p.) infected with scrapie. The results of the spatiotemporal ultrasensitive
immunoblot-detection of scrapie-associated prion protein (PrPSc) in serial nerve segments of both
distal sciatic nerves could be interpreted as a centripetal and subsequent centrifugal neural spread
of PrPSc for this route of infection. In order to determine whether this propagation is dependent on
main components in the axonal cytoskeleton (e.g. neurofilaments, also relevant for the component
‘a’ of slow axonal transport mechanisms), hamsters were treated -in an additional experiment- with
the neurotoxin ß,ß’-iminodiproprionitrile (IDPN) around the beginning of the scrapie infection. A
comparison of the Western blot signals of PrPSc in the ipsilateral and in the subsequently affected
contralateral sciatic nerve segments with the results revealed from IDPN-untreated animals at pre-
clinical and clinical stages of the TSE disease, indicated similar amounts of PrPSc. Furthermore, the
mean survival time was unchanged in both groups. This in vivo model, therefore, suggests that the
propagation of PrPSc along peripheral nerves is not dependent on an intact neurofilament compo-
nent of the axonal cytoskeleton. Additionally, the model indicates that the spread of PrPSc is not
mediated by the slow component ‘a’ of the axonal transport mechanism.
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1. INTRODUCTION
Transmissible spongiform encephalo-
pathies (TSE), such as the Creutzfeldt-
Jakob Disease (CJD) in humans, bovine
spongiform encephalopathy (BSE) in cat-
tle or scrapie in sheep are fatal diseases
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kratzelc@rki.de, kruegerd@rki.de
of the central nervous system (CNS) in
mammalians. The etiological classification
differentiates between genetic, acquired or
sporadic forms.
The key molecular pathological event,
characteristic to all forms of TSE, seems to
have been elucidated: The normal host cel-
lular prion protein (PrPC) converts into a
disease-specific form [11], that is resistant
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to proteinase K digestion [42]. The gly-
coprotein PrPC is strongly expressed by
cells of the nervous and lymphoreticular
systems. During biogenesis, PrPC migrates
to the outer plasma membrane where it is
anchored by glycosyl-phosphatidylinositol
[47]. In vivo studies showed that PrPC is
transported in nerves by axonal antero-
grade and retrograde transport mechanisms
[8,36,45]. However, the normal function of
PrPC is still unclear.
The abnormal scrapie specific prion
protein (PrPSc) is a biochemical marker for
TSE and is linked with infectivity. This
fact coupled with the failure to successfully
transmit the disease in PrPC knock-out
mice models [11], the in vitro generation of
infectious PrP [13,32] and the futile search
for specific prion-associated nucleic acids
are all strong indicators that PrPSc, accord-
ing to the protein-only hypothesis [42],
is the causative TSE agent. Post-mortem
histological examinations of brain tissue
of clinically affected individuals revealed
astrocytosis and vacuolar degeneration be-
sides the detection of antibody-positive
granular deposits of PrPSc.
The natural route of infection for ac-
quired forms of TSE is the peripheral
uptake of the infectious agent. Known
sources of iatrogenic CJD in humans are
transmission via infected grafts (cornea
or meninx), via neurosurgical devices or
transmission by the administration of hu-
man pituitary hormones [10]. There is
some evidence that TSE can be transmitted
by blood transfusion from infected donors
[33, 40]. A large number of in vivo ex-
periments suggest that the most important
epidemiological modus for scrapie, BSE
or variant-CJD (vCJD) transmission is the
oral route [2, 39]. The endemic appear-
ance of Kuru in Papua New Guinea is due
to endocannibalistic rites [1]. Nevertheless,
in vivo experiments showed successful
transmission of TSE-disease not only by
oral, intracerebral, intravenous or intraperi-
toneal application of infectivity but also by
subcutaneous injection, through defect mu-
cosa [5, 12] or, even very effectively, by
scarification of the intact skin [48].
The sequential detection of abnormal
prion protein in lymphoreticular tissue and
along neural projections to the CNS af-
ter peripheral infection in various animal
models led to the conclusion that these
tissues are involved in the spread of the
TSE agent to the CNS [3, 7, 17, 28, 35, 44,
46]. The sciatic nerve is a useful struc-
ture for monitoring the centripetal neural
spread of the scrapie agent [29] and rapid
disease onset was observed after intrasci-
atic injections of strains of transmissible
mink encephalopathy (TME) in rodents
[4]. Kimberlin [29] debated that the veloc-
ity of the spread of the scrapie agent to the
CNS is comparable to the velocity of slow
axonal transport. In all eukaryotic cells, in-
cluding neurons, intracellular transport of
membranous and nonmembranous cargoes
(e.g. vesicles, proteins, mRNA) is of vital
importance. Axonal transport proceeds in
a fast or slow manner in anterograde or ret-
rograde direction (from the cell body to the
axon tip and vice versa). With respect to
the rate and nature of moving structures,
the slow axonal transport can be distin-
guished in two components. The compo-
nent ‘a’ of slow axonal transport moves
material bidirectionally at an overall rate
of around 1 mm per day. Amongst moving
material are the main proteins of the ax-
onal cytoskeleton, neurofilament proteins
and tubulin, whereby cytoskeletal poly-
mers act as carrier structures [9]. It is still
unclear whether the development of TSE
interferes with the axonal transport of neu-
rofilaments [20].
In order to answer the question whether
axonal transport mechanisms are involved
in the spread of the infectious agent along
axons, previous studies were carried out in
four-repeat tau over-expressing mice and
in dynein mutant mice models [25, 31].
The results suggested that the fast host
retrograde axonal transport mechanism did
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not serve as a “ferry” for the centripetal
propagation of PrPSc.
In this study Syrian hamsters were uni-
laterally footpad (f.p.) infected with 263K
scrapie, approximating a natural route of
infection, in order to characterize the nor-
mal neural pathway of the disease for this
route. In a further experiment, animals
were treated with iminodiproprionitrile
(IDPN), known to disorganize neurofila-
ments and axonal transport mechanisms
[14–16, 19, 21, 23, 30, 37, 38]. We an-
alyzed Western blot signals of protease
resistant PrP from the sciatic nerve seg-
ments of f.p. infected animals in non- and
IDPN-exposed groups at the preclinical
and clinical stages of scrapie. Furthermore,
we compared the time required to reach
the terminal stage of disease, to clarify
whether the assumed centripetal spread of
the infectious agent to the CNS and its sub-
sequent centrifugal travel to the periphery
are dependent on the intact neurofilament
component of the axonal cytoskeleton.
2. MATERIALS AND METHODS
2.1. Animal inoculations
The animal experiments complied with
German legal provisions.
Adult male and female Syrian ham-
sters were sedated with isofluran and f.p.
infected with 20 µL of a 2% (wt/vol) termi-
nally ill 263K-hamster brain homogenate
or mock-infected with normal hamster
brain homogenate in the sole of the right
foot by injection using a 27 gauge cannula.
The animals were regularly monitored for
clinical signs of scrapie ranging from an in-
creased sensitivity to touch and sound to
muscle tremor, kiphosis, ataxia and rapid
weight loss.
2.2. Tissue collection for spatiotemporal
PrPSc analysis in sciatic nerves after
f.p. infection
The hamsters were sacrificed by CO2
asphyxiation at different time points
following infection or when terminally
ill. Samples of both distal sciatic nerves
were divided into quarters weighing
3.6 ± 1.4 mg (mean ± SD) for Western
blot analyses. Specimens were TBS-
washed and frozen at –80 ◦C immediately
after preparation until further processing.
To avoid cross-contamination, the instru-
ments used for the preparation of samples
were carefully cleaned after removal and
processing of each specimen.
Western blot results were reported for
samples at the following time points:
2 days post infection (dpi, n = 2), 42 dpi
(n = 5), 60 dpi (n = 2), 70 dpi (n = 6),
80 dpi (n = 6), 90 dpi (n = 7), 100 dpi
(n = 4) and when terminally ill with se-
vere symptoms at 100 dpi (n = 6) and
119 dpi (n = 2), and for samples of mock-
infected hamsters manifesting no clinical
signs which were sacrificed at 42 dpi and
at > 100 dpi.
Other animals were transcardially per-
fused with periodate-lysine-paraformal-
dehyde (PLP [34]); nerve and brain sam-
ples were removed and post-fixed for 4 h
in PLP or the removed tissue was di-
rectly immersion fixed for a maximum of
48 h with neutral buffered 3.7% forma-
lin. Tissue samples for immunohistochem-
istry (IHC) were taken 42 dpi, 70 dpi,
80 dpi, 90 dpi, 100 dpi (a total of n =
4 preparations for every time point) and
when terminally ill at 104 dpi and 110 dpi
(n = 2, respectively). After incubation in
phosphate-buffered saline, tissue samples
were transferred to 70% ethanol, processed
in a tissue processor and subsequently em-
bedded in paraffin wax.
2.3. Chronic IDPN intoxication and
spatiotemporal tissue collection for
PrPSc analysis
A tolerable treatment regime for IDPN
intoxication was determined in prelimi-
nary tests. Hamsters were f.p. infected and
treated intraperitoneally (i.p.) five times
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with IDPN (20 mg/100 g). The first injec-
tion was administrated 10 days before and
the final injection 28 days after infection.
Before administration, IDPN was diluted
in saline and the pH was adjusted with
hydrochloric acid to 7.4. Nerve tissue of
a mock-infected, a scrapie-infected and a
scrapie-infected IDPN-intoxicated hamster
at 42 dpi (PLP fixed as described above)
were the controls for immunohistological
analysis to confirm the effect of the intoxi-
cation.
At 45 dpi peripheral blood of 6 un-
treated and 7 IDPN-treated animals was
collected by puncturing the retrobulbar
plexus. White blood cells were quan-
titatively and qualitatively compared by
counting using a hemocytometer and by
Giemsa staining of a blood smear.
Analogous to untreated hamsters, the
IDPN-treated animals were sacrificed at
different time points following infection
or when terminally ill. Samples of both
distal sciatic nerves were divided into quar-
ters weighing 3.4 ± 1.3 mg (mean ± SD)
for Western blot analyses. Specimens were
TBS-washed and frozen at –80 ◦C imme-
diately after preparation until further pro-
cessing. Western blot results were reported
for samples at the following time points:
42 dpi (n = 4), 60 dpi (n = 4), 70 dpi (n =
4), 80 dpi (n = 4), 90 dpi (n = 4), 100 dpi
(n = 2) and when terminally ill with se-
vere symptoms at 109 and 126 dpi (n =
2). Mock-infected and IDPN-treated ham-
sters without clinical signs were sacrificed
42 dpi and at> 100 dpi. For histological in-
vestigations, nerve and brain samples were
removed 42 dpi (n = 4), 60 dpi (n = 4),
70 dpi (n = 4), 80 dpi (n = 4), 90 dpi,
100 dpi (n = 3) and when terminally ill at
112 dpi (n = 1), fixed in PLP or formalin
and processed as described above.
The incubation times until the de-
velopment of terminal scrapie disease
were determined in separate groups with
IDPN-treated (n = 7) or nontreated ani-
mals (n = 4).
2.4. Western blot
For positive controls, nerve samples of
uninfected animals were spiked with 10 µL
of 0.1% 263K-hamster brain homogenate
(corresponding to 10−5 g of scrapie brain
homogenate) prepared by ultrasonification
of 1 g brain tissue of a terminally ill
donor hamster in 10 mL Tris-buffer, pH
7.4. All nerve samples were incubated at
37 ◦C for 60 min with 500 µL 0.25% col-
lagenase in TBS buffer containing 2 mM
CaCl2. After halting the reaction by adding
10 µL 250 mM EDTA, tissue-extraction
of PrPSc in the form of the protease re-
sistant 27–30 kD fragment (PrP27-30) was
initiated in line with a previously pub-
lished protocol [6], including the use of
proteinase K (PK) to destroy normal PrPC.
The final pellets were resuspended with
20 µL of 2 × sample loading buffer and
heated to 100 ◦C for 10 min prior to West-
ern blotting using the monoclonal anti-
PrP antibody (mAb) 3F4 [27] and an al-
kaline phosphatase-conjugated secondary
goat-anti-mouse antibody. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blot analyses
were performed as described elsewhere
[6, 49]. Antibody binding was visualized
using CDP-Star (Tropix) as a chemolumi-
nescent substrate for alkaline phosphatase
and a Kodak X-OMAT AR film, exposed
for 30–60 min.
2.5. Immunohistochemistry
For the detection of granular PrPSc,
2 µm thick paraffin slides were pre-
treated with guanidiniumthiocyanate af-
ter deparaffinization and rehydration and
heating in citrate buffer in a microwave.
After blocking with 0.2% (wt/vol) ca-
sein (Tropix), the slides were first in-
cubated with mAb 3F4, diluted 1:250
in blocking solution for 90 min at
room temperature followed by incuba-
tion for 60 min at room temperature
with an alkaline phosphatase-conjugated
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goat-anti-mouse antibody (DakoCytoma-
tion), diluted 1:500 in blocking solu-
tion. Immunostaining was performed using
new fuchsine as substrate for alkaline
phosphatase. On selected sections, 3F4
binding was visualized using a biotin-
conjugated goat-anti-mouse antibody, the
avidin biotin-complex (Vectastain) tech-
nique and with diaminobenzidine (DAB)
as a chromogen. DAB-stained sections
were pre-treated with amino acid after
deparaffinization. Subsequently, the slides
were counterstained with hemalaun.
To verify the effects of IDPN, sections
of sciatic nerve tissues were stained using,
as the first antibody, a marker for neuro-
filaments (mAb 2F11, DakoCytomation),
diluted 1:100 in phosphate-buffered saline
and a fluorescent (Oregon green) labelled
secondary antibody, diluted 1:100. 2F11
reacts with the phosphorylated form of a
70 kD component of the three neurofil-
ament major polypeptide units. An unin-
fected/untreated animal and an uninfected/
IDPN-treated animal as well as a 263K
infected/IDPN-treated animal were com-
pared at 42 dpi.
3. RESULTS
3.1. Spatiotemporal PrPSc analysis in
sciatic nerves after f.p. infection
After unilateral infection in the right
foot pad of hamsters with 263K brain
homogenate, the scrapie specific clinical
phase started with the symptom of muscle
tremor around 78 dpi.
To determine the distribution of PrPSc in
nerve tissue at different time points, quar-
ters of both distal sciatic nerves (femural
level) were collected and Western blots of
the nerve segments were performed after
extraction and PK digestion in order to de-
tect only protease resistant PrPSc in the
form of PrP27-30. Figure 1 shows the typ-
ical results for the Western blot detection
of PrP27-30 at different time points in se-
rial segments of ipsilateral (lanes 2-5 in
A-G) and contralateral sciatic nerves (lanes
2-5 in H-N) of one animal, respectively.
Nerve segments and spiked nerve segments
of uninfected animals served as negative
and positive controls for the PrP27-30 ex-
traction procedure. Additionally, controls
for blotting efficiency (lane 9 in A-N) were
carried out to align the signal intensities.
No noticeable signals for PrP27-30 in seg-
ments of both nerves were detectable 2 dpi
(data not shown) and 42 dpi (Fig. 1). The
f.p. infection led to the first clear detec-
tion of PrP27-30 in the ipsilateral sciatic
nerves at 60 dpi, earlier than in contralat-
eral nerves (around 80 dpi). The time frame
from finding the first weak signals up to
finding strong signals in the nerves was
very short (about 10–20 days). Western
blot results indicate an increasing level of
PrPSc in the sciatic nerves at the respective
site with time, whereby signal intensities of
segments of one nerve did not differ sub-
stantially.
Immunohistological examinations of
the brain revealed the tendency for the
region of the contralateral red nucleus
(RN), correlating with the ipsilateral sci-
atic nerve, to show stronger granular PrP-
immunoreactive signals than the red nu-
cleus of the other side (Fig. 2).
Granular PrP-positive deposits could be
detected very rarely in the sciatic nerve.
Figure 3 shows a cross section through the
sciatic nerve with central axons, peripher-
ally surrounded by myelin sheats. The light
microscopical investigations indicated that
the deposits were located at the axonal pe-
riphery, in a close position to the myelin
sheath.
3.2. Effects of IDPN-treatment,
spatiotemporalPrPSc analysis
in sciatic nerves after f.p. infection
in neurotoxin-exposed animals and
survival after infection
The IDPN-dose and treatment regime
were well tolerated in all animals. One
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Figure 1. Detection of PrP27-30. Representative Western blots of ipsilateral (A-G) and contralateral
(H-N) sciatic nerve tissue of 263K f.p. infected hamsters for indicated time points after infection.
Lane 1: marker; lanes 2-5: sciatic nerve quarters from proximal to distal of the same individual at
the indicated time point (samples correspond to the following amounts of tissue (mg): A2, 2.4; A3,
2.1; A4, 2.9; A5, 4.7; B2, 3.3; B3, 3.2; B4, 3.3; B5, 5.2; C2, 2.4; C3, 2.3; C4, 2.2; C5, 8.7; D2,
3.0; D3, 2.6; D4, 3.1; D5, 6.1; E2, 4.1; E3, 3.9; E4, 4.7; E5, 5.5; F2, 4.5; F3, 2.2; F4, 4.0; F5, 5.5;
G2, 2.9; G3, 2.6; G4, 3.9; G5, 3.0; H2, 3.1; H3, 3.0; H4, 2.2; H5, 5.5; I2, 5.5; I3, 2.8; I4, 4.2; I5,
4.8; J2, 3.0; J3, 2.6; J4, 2.4; J5, 2.8; K2, 3.0; K3, 2.6; K4, 3.0; K5, 3.9; L2, 3.1; L3, 3.5; L4, 3.6;
L5, 10.5; M2, 2.8; M3, 1.9; M4, 2.2; M5, 4.8; N2, 3.4; N3, 3.8; N4, 2.6; N5, 4.0); lane 7 (A, C,
G, I, K, L, M): spiked processing controls, 10−5 g 263K brain homogenate (samples correspond to
the following amounts of normal sciatic nerve tissue (mg): A7, 7.5; C7, 2.3; G7, 2.6; I7, 6.4; K7,
2.5; L7, 1.5; M7, 2.7); lane 7 (B, D, E, F, H, J, N): uninfected nerves as controls for PK digestion
(samples correspond to the following amounts of normal sciatic nerve tissue (mg): B7, 2.6; D7, 2.8;
E7, 1.8; F7, 2.6; H7, 2.9; J7, 2.2; N7, 2.5); lane 9: blot controls, 10−6 g 263K brain homogenate.
Lanes 6 and 8 were loaded with LPP.
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Figure 2. Representative micrograph for im-
munohistological staining of a 6 µm brain sec-
tion of a f.p. infected hamster 70 dpi using mAb
3F4 and DAB as chromogen, without counter-
staining. Brown deposits for PrPSc accumulate
early in both red nuclei. There are slightly
stronger deposits in the contralateral red nu-
cleus (cRN). (A color version of this figure is
available at www.edpsciences.org/vetres.)
observed side effect was the occurrence
of temporary salivation 30 min after i.p.
injection. One week after the last IDPN-
application (45 dpi), peripheral blood of
separated animals was collected for mon-
itoring general inflammatory side effects.
The number and morphology of white
blood cells were comparable in IDPN-
treated and untreated animals (data not
shown).
In further selected animals, tissue sam-
ples for immunohistological examinations
were taken two weeks after the last IDPN-
application to verify the neural effects of
the neurotoxin. Immunolabeling of neuro-
filaments using the mAb 2F11 showed that
peripheral nerve tissue of IDPN-exposed
hamsters had a stronger immunoreactiv-
ity than nerve tissue of untreated animals
(Fig. 4).
After scrapie f.p. infection, the disease-
specific clinical phase started in the IDPN-
treated animals, similar to the non-IDPN-
treated animals, with symptoms of muscle
tremor around 80 dpi.
Figure 3. Representative micrograph for im-
munohistological staining of a 1 µm ipsilateral
sciatic nerve section of a f.p. infected animal
(PLP-fixed tissue) at 80 dpi using mAb 3F4 and
new fuchsine as chromogen. Red deposit (ar-
row) for PrPSc. (A color version of this figure
is available at www.edpsciences.org/vetres.)
Figure 5 indicates no difference in sur-
vival after scrapie infection in non-treated
and IDPN-treated animals (106± 5 dpi and
105 ± 4 dpi, respectively, mean ± SD).
Temporal Western blot signal intensities
for PrP27-30 in serial nerve segments at all
time points indicated comparable amounts
of PrPSc in analogous sciatic nerve seg-
ments in IDPN- and non-IDPN-treated an-
imals for both ipsilateral or contralateral
nerves (Fig. 6, compare with Fig. 1).
4. DISCUSSION
We chose an in vivo model mimick-
ing injuries as a possible natural exposure
to the TSE agent [48]. However, periph-
eral uptake via ingestion is the most likely
route of exposure for several TSE diseases.
Experimental oral infection of hamsters
with 263K scrapie required high doses and
resulted in relatively long incubation peri-
ods until the terminal stage of the disease
was reached [43, 49]. In contrast, footpad
infection with lower doses showed a rel-
atively short mean incubation time with
small variance, characterizing this route as
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Figure 4. Cross sections of the distal sciatic nerve of an untreated animal (A) and an IDPN-treated
animal (B). Immunostaining with a neurofilament antibody showed strong immunoreactivity in the
IDPN-treated animal (confocal laser scanning microscopy, magnification ×400.) (A color version
of this figure is available at www.edpsciences.org/vetres.)
Figure 5. Mean survival time (dpi) after foot-
pad scrapie infection with 20 µL 2% 263K brain
homogenate in neurotoxin exposed and non-
exposed hamsters
very effective. Therefore, skin lesions or
injuries may be a relevant natural site of
entry for the TSE agent.
Western blot analyses of protease re-
sistant prion protein in both distal sciatic
nerves and the immunohistochemical de-
tection of PrPSc in the corresponding brain
areas after unilateral footpad infection with
the scrapie agent (Figs. 1 and 2) pointed
to the postulated centripetal propagation to
the CNS and to the subsequent centrifugal
spread of PrPSc along nerval projections:
Cell bodies of the sciatic nerves are lo-
calized in the spinal cord. Corresponding
areas in the brain of the sciatic nerve are
the red nuclei. As most prominent projec-
tions, nerve fibers arising in the cells of
RN cross ventral to the nuclei and course
within the lateral funiculi of the spinal cord
(Tractus rubrospinalis).
Spread along nerval projections was
also suggested by Kimberlin [29] and
Bartz [4] for the intrasciatic route of exper-
imental scrapie- or TME-infection. More-
over, Kimberlin [29] assumed that the in-
trasciatic route bypasses extraneural agent
replication. Nevertheless, for the footpad
route, extraneural loci of agent replication
cannot be ruled out since early and contin-
uous accumulation of PrPSc could also be
detected in the regional lymphoid system
(data not shown). However, up to now no
method has been available to differentiate
between the exogenously administered and
endogenously formed pathological prion
protein.
Our immunohistological investigations
of the distal sciatic nerve concerning
the localisation of PrPSc rarely showed
granular PrP-positive deposits, located ap-
parently between the myelin sheath and
axon. However, it was not possible to
exactly determine the axonal or extraax-
onal location of these depositions by light

























Figure 6. Detection of PrP27-30. Representative Western blots of ipsilateral (A-G) and contralateral
(H-N) sciatic nerve tissue of 263K f.p. infected and IDPN-treated hamsters for indicated time points
after infection. Lane 1: marker; lanes 2-5: sciatic nerve quarters from proximal to distal of the same
individual at the indicated time point (samples correspond to the following amounts of tissue (mg):
A2, 2.6; A3, 2.5; A4, 2.9; A5, 4.6; B2, 1.2; B3, 1.0; B4, 1.5; B5, 1.9; C2, 2.5; C3, 2.1; C4, 2.0; C5,
3.7; D2, 2.9; D3, 1.9; D4, 2.9; D5, 3.3; E2, 6.2; E3, 4.3; E4, 4.5; E5, 5.5; F2, 3.9; F3, 3.3; F4, 3.5;
F5, 5.6; G2, 2.6; G3, 2.1; G4, 1.9; G5, 2.8; H2, 5.4; H3, 2.8; H4, 4.4; H5, 4.0; I2; 1.8; I3, 1.7; I4,
1.4; I5, 1.6; J2, 2.1; J3, 2.2; J4, 2.2; J5, 4.6; K2, 3.4; K3, 3.3; K4, 3.4; K5, 4.4; L2, 4.9; L3, 4.1; L4,
3.4; L5, 5.0; M2, 4.7; M3, 3.1; M4, 3.3; M5, 4.0; N2, 3.1; N3, 1.7; N4, 2.6; N5, 4.8); lane 7 (B, C,
D, F, H, L, N): spiked processing controls, 10−5 g 263K brain homogenate (samples correspond to
the following amounts of normal sciatic nerve tissue (mg): B7, 2.5; C7, 2.7; D7, 3.5; F7, 2.5; H7,
2.4; L7, 1.9; N7, 2.7); lane 7 (A, E, G, I, J, K, M): uninfected nerves as controls for PK digestion
(samples correspond to the following amounts of normal sciatic nerve tissue (mg): A7; 3.6; E7, 1.6;
G7, 2.2; I7, 3.0; J7, 2.3; K7, 2.7; M7, 2.1); lane 9: blot controls, 10−6 g 263K brain homogenate.
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microscope. Groschup et al. [24] suggested
adaxonal location of PrPSc deposits in pe-
ripheral nerves for the i.p. route of infec-
tion.
Western blot signals for PrP27-30 from
the sciatic nerve segments did not indicate
any clear direction of PrPSc-propagation:
the blot signal intensities from all seg-
ments of a unilateral nerve in the same
individual at one time point were almost
equal (Figs. 1 and 6). This may be due
to the limited resolution of the detection
method and/or to the comparative obser-
vations along a relatively short neural dis-
tance (quarters of a length of 2–3 cm
nerve). Another possible explanation may
be that the infectious agent rapidly passes
neural tissue at earlier points in time of the
incubation period, something that is also
assumed for vagal transit [35].
Another objective of this study was to
identify or narrow down potential mecha-
nisms for the neural centripetal/centrifugal
propagation of the TSE agent. In order to
determine whether this propagation is de-
pendent on an intact axonal cytoskeleton
we studied the spread of scrapie in IDPN
intoxicated animals. The effects of IDPN
as a toxin causing changes in cytoskele-
tal architecture and in axonal transport of
proteins are well characterized by various
in vivo models including a broad range
of species (e.g. rats, cats, chickens, guinea
pigs). IDPN treatment induces structural
abnormalities in axonal segments [14, 15],
neurofilaments displace toward the axonal
periphery while microtubuli displace to-
ward the axonal center [23, 37]. Giant
axonal swellings appear, containing malo-
riented neurofilaments [16]. In motor end
plates, the immunoreactivity of neurofil-
aments is decreased [18]. The neuronal
cytoskeleton in IDPN-treated animals can
be characterized as “disorganized”. Several
data indicate that axonal transport mech-
anisms are impaired: predominantly the
slow anterograde ones but also the retro-
grade and fast ones [19, 21, 30, 38]. Com-
pared to the doses described in the litera-
ture for experiments with various species,
the administered dose in the present study
ranged in the lower level. Chronic low
dose intoxication with IDPN in our test
animals induced an increased immunore-
activity of neurofilaments in sections of the
distal sciatic nerve, confirming an effect on
the axonal cytoskeleton. Regardless of pos-
sible changes in the phosphorylation status
of the neurofilament proteins leading to a
possibly higher affinity to the antibody la-
belling of the neurofilaments, we would in-
terpret this observation as indicating an en-
richment of neurofilaments in distal axons,
analogous to results in IDPN-intoxicated
cats [22]. Moreover, based on visual sub-
jective judgement, the axonal diameter
seemed to be slightly increased (Fig. 4).
The occurrence of salivation shortly after
i.p. application in hamsters could be the ef-
fect of the neurotoxin on neurotransmitters
involved in the control of salivary gland
secretion. The quality and quantity of the
animals’ white blood cells suggested that
there was no evidence of general inflam-
mation caused by IDPN-treatment regime.
Inflammations were shown to have an in-
fluence on the detection of PrPSc or on
scrapie pathogenesis [26].
A comparison of the incubation times
in neurotoxin exposed and unexposed ani-
mals (Fig. 5) led to the assumption that the
neuroinvasive progression of disease is in-
dependent of the neurofilament component
of the axonal cytoskeleton. Moreover, the
comparison of the results of spatiotemporal
PrPSc detection in sciatic nerves without or
with IDPN treatment (Figs. 1 and 6) did not
indicate any influence of the axonal neuro-
filament component on the propagation of
the pathological prion protein in peripheral
nerves.
One conceivable mode of transportation
along peripheral nerves for the abnormal
prion protein is the host’s axonal transport
machinery. Although the molecular basis
is not completely understood, members
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of the Herpesviridae family are examples
of agents using this transport system [50]
as well as neurotoxins (i.e. tetanus toxin,
[41]). IDPN intoxication mainly affects the
slow axonal transport mechanism. Regard-
ing the relevance of neurofilaments for
slow component ‘a’ [9], the IDPN model
has the potential to specify the influence
of host slow axonal transport mechanism
‘a’ on propagation of PrPSc. Although the
degree of impairment of the axonal flow
achieved by IDPN-intoxication was not
monitored in this study, it is strongly indi-
cated that axonal propagation of PrPSc does
not correlate with the slow axonal transport
system component ‘a’.
Finally, we only focused on the neu-
ronal pathway and its structural-functional
modification in one TSE in vivo model.
Alternative pathways of spreading should
be examined, too, including simultaneous
observations of other tissues. Further in-
vestigations are necessary to elucidate the
impact of neuronal vs. nonneuronal path-
ways for the footpad model.
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